natgillin/translations-raw huggingface dataset:
• swollen lymph glands (glands in the neck, armpit or groin)
• oteklina bezgavk (žleze v vratu, podpazduhi ali dimljah);
• redness at the injection site
• rdečina na mestu injiciranja,
What Priorix contains To be completed nationally
Kaj vsebuje cepivo Priorix [izpolni država članica]
Blood and lymphatic system disorders: Thrombocytopenia, thrombocytopenic purpura
Bolezni krvi in limfatičnega sistema: Trombocitopenija, trombocitopenična purpura
Respiratory, thoracic and mediastinal disorders: Uncommon: bronchitis, cough
Bolezni dihal, prsnega koša in mediastinalnega prostora: Občasni: bronhitis, kašelj
PHARMACEUTICAL FORM AND CONTENTS To be completed nationally
FARMACEVTSKA OBLIKA IN VSEBINA [izpolni država članica]
Blood and lymphatic system disorders: Uncommon: lymphadenopathy
Bolezni krvi in limfatičnega sistema: Občasni: limfadenopatija
Priorix must not be administered to pregnant women.
Cepiva Priorix se nosečnicam ne sme dati.
In case of inadvertent vaccination of pregnant woman with Priorix, this should not be a reason for termination of pregnancy.
Če ženska, ki ne ve, da je noseča, nevede prejme cepivo Priorix, to ni razlog za prekinitev nosečnosti.
Transmission
Prenašanje
Seroconversion rates for measles, mumps and rubella were 92.6%, 91.5% and 100%, respectively.
Delež serokonverzije za ošpice je bil 92,6 %, za mumps 91,5 % in 100 % za rdečke.
As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.
Pri cepljenju je, tako kot pri vseh cepivih, ki se jih injicira, treba zagotoviti ustrezno obliko zdravljenja in nadzora, ki bo v takšnem primeru nemudoma na voljo.
How to store Priorix
Kako uporabljati cepivo Priorix
Your doctor may delay vaccination for at least 3 months if you or your child has received a blood transfusion or human antibodies (immunoglobulins).
Če ste vi ali vaš otrok prejeli transfuzijo krvi ali humana protitelesa (imunoglobuline), bo zdravnik lahko cepljenje s cepivom Priorix odložil vsaj za 3 mesece.
Side effects that occurred during clinical trials with Priorix were as follows:
Med kliničnimi preskušanji cepiva Priorix so se pojavili naslednji neželeni učinki:
Transmission of the rubella vaccine virus to infants via breast milk as well as transplacental transmission has been documented without any evidence of clinical disease.
Dokumentirano je prenašanje virusa iz cepiva proti rdečkam na dojenčke z materinim mlekom; prav tako je dokumentirano transplacentalno prenašanje.
Rare: allergic reactions
Bolezni imunskega sistema: Redki: alergijske reakcije
Uncommon: conjunctivitis
Očesne bolezni: Občasni: konjunktivitis
How Priorix works
Kako cepivo Priorix deluje
Very common: redness at the injection site, fever 38°C (rectal) or 37.5°C (axillary/oral) Common: pain and swelling at the injection site, fever >39.5°C (rectal) or >39°C (axillary/oral)
Pogosti: bolečina in oteklina na mestu injiciranja, zvišana telesna temperatura > 39,5 °C (rektalno) ali  39,0 °C (aksilarno/oralno)
Immunocompromised patients who have no contraindication for this vaccination (see section 4.3) may not respond as well as immunocompetent patients, therefore some of these patients may acquire measles, mumps or rubella in case of contact, despite appropriate vaccine administration.
Imunsko oslabeli bolniki, ki nimajo kontraindikacij za to cepljenje (glejte poglavje 4.3), se lahko odzovejo slabše kot imunokompetentni bolniki.
This leaflet was last revised in {MM/YYYY} To be completed nationally
Navodilo je bilo odobreno {MM/YYYY}: [izpolni država članica]
No adverse reactions have been associated to the overdose.
Preveliko odmerjanje ni bilo povezano s pojavom neželenih učinkov.
In these cases, the vaccination will be postponed until recovery.
V tem primeru se bo cepljenje odložilo, dokler vi ali vaš otrok ne boste ozdraveli.
 Very common (these may occur with more than 1 in 10 doses of the vaccine):
Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 odmerkov cepiva):
• if you or your child has disorders of the central nervous system, a history of convulsion accompanying high fever or family history of convulsions.
• če imate vi ali vaš otrok bolezen osrednjega živčevja, ste vi/je vaš otrok kdaj imel vročinske krče ali pa so se krči pojavljali v družini.
STATEMENT OF ACTIVE SUBSTANCE(S) To be completed nationally
SEZNAM POMOŽNIH SNOVI [izpolni država članica]
METHOD OF ADMINISTRATION
Način uporabe
INFORMATION IN BRAILLE To be completed nationally
PODATKI V BRAILLOVI PISAVI [izpolni država članica]
Rare: febrile convulsions
Bolezni živčevja: Redki: vročinski krči
• rash (spots)
• izpuščaj (pikice);
What you need to know before you or your child receive(s) Priorix
Kaj morate vedeti, preden boste prejeli cepivo Priorix
6.4 Special precautions for storage
6.4 Posebna navodila za shranjevanje [izpolni država članica]
1%, against mumps in 94.4% and against rubella in 100% of previously seronegative vaccinees.
Cepljenje z enim samim odmerkom cepiva PRIORIX je sprožilo nastanek protiteles proti ošpicam pri 98,1 %, proti mumpsu pri 94,4 % in proti rdečkam pri 100 % pred tem seronegativnih cepljenih otrok.
Uncommon: anorexia
Presnovne in prehranske motnje: Občasni: anoreksija
 Rare (these may occur with up to 1 in 1,000 doses of the vaccine):
Redki (pojavijo se lahko pri največ 1 od 1.000 odmerkov cepiva):
Skin and subcutaneous tissue disorders: Common: rash
Bolezni kože in podkožja: Pogosti: izpuščaj
Individuals who have experienced anaphylaxis after egg ingestion should be vaccinated with extreme caution, with adequate treatment for anaphylaxis on hand should such a reaction occur.
Treba je zagotoviti takojšnje ustrezno zdravljenje anafilaksije, če se takšna reakcija pojavi.
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION SC or IM See Annex I - To be completed nationally
IME ZDRAVILA IN POT(I) UPORABE s.c. ali i.m.
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION See Annex I - To be completed nationally
IME ZDRAVILA IN POT(I) UPORABE [glejte Prilogo I - izpolni država članica]
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS VIAL WITH POWDER
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Talk to the doctor or pharmacist before you or your child receives Priorix :
Pred cepljenjem s cepivom Priorix se posvetujte s svojim zdravnikom ali farmacevtom:
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER <See Annex I - To be completed nationally>
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM [glejte Prilogo I - izpolni država članica]
The vaccine should never be given into a vein.
Cepiva Priorix se v nobenem primeru ne sme injicirati v žilo.
If tuberculin testing has to be done it should be carried out before or simultaneously with vaccination since it has been reported that combined measles, mumps and rubella vaccines may cause a temporary depression of tuberculin skin sensitivity.
Poročila namreč navajajo, da lahko kombinirana cepiva proti ošpicam, mumpsu in rdečkam začasno zmanjšajo občutljivost kože za tuberkulin.
Uncommon: nervousness, abnormal crying, insomnia Nervous system disorders:
Psihiatrične motnje: Občasni: živčnost, neobičajen jok, nespečnost
Cases of worsening of thrombocytopenia and cases of recurrence of thrombocytopenia in subjects who suffered thrombocytopenia after the first dose have been reported following vaccination with live measles, mumps and rubella vaccines.
Po cepljenju z živimi cepivi proti ošpicam, mumpsu in rdečkam so bili opisani primeri poslabšanja trombocitopenije ter primeri ponovitve trombocitopenije pri osebah, ki se jim je trombocitopenija pojavila po prvem odmerku.
PRIORIX SHOULD UNDER NO CIRCUMSTANCES BE ADMINISTERED INTRAVASCULARLY.
Cepiva Priorix v nobenem primeru ne smete injicirati v žilo.
Ask your pharmacist how to throw away medicines you or your child no longer use(s).
O načinu odstranjevanja cepiva, ki ga ne potrebujete več, se posvetujte s farmacevtom.
If you or your child get(s) any side effects, talk to your doctor or pharmacist.
Če opazite kateri koli neželeni učinek, se posvetujte s svojim zdravnikom ali s farmacevtom.
- Keep this leaflet.
Pred uporabo pretresite.
• diarrhoea
• nespečnost;
Common: upper respiratory tract infection Uncommon: otitis media
Infekcijske in parazitske bolezni: Pogosti: okužba zgornjih dihal Občasni: vnetje srednjega ušesa
 Common (these may occur with up to 1 in 10 doses of the vaccine):
Pogosti (pojavijo se lahko pri največ 1 od 10 odmerkov cepiva):
NAME OF THE MEDICINAL PRODUCT See Annex I - To be completed nationally
IME ZDRAVILA [glejte Prilogo I - izpolni država članica]
 Uncommon (these may occur with up to 1 in 100 doses of the vaccine):
Občasni (pojavijo se lahko pri največ 1 od 100 odmerkov cepiva):
PRIORIX is for subcutaneous injection, although it can also be given by intramuscular injection.
Cepivo PRIORIX injicirajte subkutano.
What you need to know before you or your child receive(s) Priorix Priorix should not be given
Cepiva Priorix vi ali vaš otrok ne smete prejeti
Marketing Authorisation Holder and Manufacturer <See Annex I - To be completed nationally>
Imetnik dovoljenja za promet s cepivom [glejte Prilogo I - izpolni država članica]
Package leaflet: information for the user See Annex I - To be completed nationally
Navodilo za uporabo [glejte Prilogo I - izpolni država članica]
MARKETING AUTHORISATION HOLDER
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM
Gastrointestinal disorders: Uncommon: parotid gland enlargement, diarrhoea, vomiting
Bolezni prebavil: Občasni: oteklina obušesne slinavke, driska, bruhanje
4 (4 x 1) vials (multipack)
Škatla s 4 (4 x 1) vialami (skupno pakiranje)
MA (EU) number (Invented) name Strength Pharmaceutical Form
(Izmišljeno) Ime Jakost
1 vial
Škatla z 1 vialo
ATCvet code: QI09AL01.
Oznaka ATC vet: QI09AL01.
Date of first authorisation: 08/07/2014 Date of latest renewal:
Datum pridobitve dovoljenja za promet: 08/07/2014 Datum zadnjega podaljšanja dovoljenja za promet:
Each dose of 2 ml contains:
Vsak 2-mililitrski odmerek vsebuje:
E. rhusiopathiae: three weeks after completion of the basic vaccination scheme.
E. rhusiopathiae: tri tedne po zaključku osnovne sheme cepljenja.
Basic vaccination:
Osnovno cepljenje:
Revaccination should be performed prior to each gestation, see section 4.9.
Revakcinacijo je treba izvesti pred vsako brejostjo, glejte poglavje 4.9.
Pigs from 6 months of age which have not been previously vaccinated with the product should be given two injections with an interval of 3-4 weeks.
Pri prašičih, starih 6 mesecev ali več, ki še niso bili cepljeni s tem cepivom, je treba dati dve injekciji z razmikom 3-4 tednov.
A single injection should be given 2-3 weeks prior to each subsequent mating (approximately every 6 months).
Eno injekcijo je treba dati 2-3 tedne pred vsakim naslednjim parjenjem (približno vsakih 6 mesecev).
Porcine parvovirus: from the beginning of the gestation period.
Prašičji parvovirus: od začetka brejosti.
LABORATORIOS HIPRA, S.A. Carretera C-63, km 48.300, Polígono Industrial El Rieral 17170 Amer (Girona) SPAIN
Carretera C-63, km 48.300, Polígono Industrial El Rieral17170 Amer (Girona) Španija
Do not use this veterinary medicinal product after the expiry date which is stated on the label after EXP.
Zdravila za uporabo v veterinarski medicini po datumu izteka roka uporabnosti, navedenega na etiketi poleg oznake EXP, ne smete uporabljati.
ERYSENG PARVO suspension for injection for pigs
ERYSENG PARVO suspenzija za injiciranje za prašiče
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the product mentioned above.
Ni podatkov o varnosti in učinkovitosti tega cepiva, če ga uporabljate s katerim drugim veterinarskim izdelkom, razen za zgoraj omenjeno cepivo.
Shelf life after mixing with UNISTRAIN PRRS: 2 hours.
Rok trajanja po tem, ko ga zmešate z UNISTRAIN PRRS: 2 uri.
The second injection should be administered 3-4 weeks before mating.
Drugo injekcijo je treba dati 3-4 tedne pred parjenjem.
Pharmacotherapeutic group: Immunologicals for suidae, Inactivated viral and bacterial vaccines.
Farmakoterapevtska skupina: Imunološka zdravila za prašiče, inaktivirana virusna in bakterijska cepiva.
Special precautions for use in animals: None.
Posebni previdnostni ukrepi za uporabo pri živalih: Jih ni.
For the active immunisation of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2.
Za aktivno imunizacijo merjascev in plemenskih svinj za zmanjšanje kliničnih znakov (kožnih lezij in vročine) rdečice, ki jo povzroča bakterija Erysipelothrix rhusiopathiae, serotip 1 in serotip 2.
Store and transport refrigerated (2 °C - 8 °C).
Shranjujte in prevažajte pri temperaturi (2 °C - 8 °C).
Adjuvants:
Ddodatki:
Porcine parvovirus: vaccination provides foetal protection for the duration of gestation.
Prašičji parvovirus: cepljenje zagotavlja zaščito ploda v času trajanja brejosti.
Major incompatibilities: Do not mix with any other veterinary medicinal product except with UNISTRAIN PRRS.
Inkompatibilnosti: Ne mešajte z nobenim drugim zdravilom razen pri UNISTRAIN PRRS.
Administer one dose of 2 ml by intramuscular injection in the neck muscles according to the following schedule:
En 2-mililitrski odmerek aplicirajte z intramuskularno injekcijo v vratno mišičevje po naslednjem razporedu:
A single dose (2 ml) of the mixed vaccines should be injected within a period of 2 hours via intramuscular use.
2-mililitrski odmerek mešanega cepiva morate injicirati v roku dveh ur preko intramuskularne uporabe.
Do not use in case of hypersensitivity to the active substances, to the adjuvants or to any of the excipients.
Ne uporabite v primeru preobčutljivosti na zdravilne učinkovine, na dodatke ali na katero koli pomožno snov.
In case of adverse reactions following accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Če se po nenamernem samoinjiciranju pojavijo neželeni učinki, se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino.
Revaccination should be performed prior to each gestation, refer to section “Dosage for each species, route(s) and method of administration”.
Revakcinacijo je treba izvesti pred vsako brejostjo, glejte poglavje »Odmerki za posamezne živalske vrste ter pot(i) in način uporabe zdravila« .
For the active immunisation of female pigs for the protection of progeny against transplacental infection caused by porcine parvovirus.
Za aktivno imunizacijo plemenskih svinj za zaščito potomstva pred transplacentarno okužbo, ki jo povzroča prašičji parvovirus.
E. rhusiopathiae: vaccination protects against swine erysipelas until the time of the recommended revaccination (approximately six months after the basic vaccination scheme), see section 4.9.
E. rhusiopathiae: cepljenje varuje pred rdečico do takrat, ko je priporočena revakcinacija (približno šest mesecev po osnovni shemi cepljenja), glejte poglavje 4.9.
Do not mix with any other veterinary medicinal product, except with UNISTRAIN PRRS.
Ne mešajte z nobenim drugim zdravilom, razen z UNISTRAIN PRRS.
The excipients (including adjuvants) listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product.
Uredbe Komisije (EU) št.37/2010 določa, da MRL ni potreben ali pa, kot so uporabljene v tem zdravilu za uporabo v veterinarski medicini, niso vključene v Uredbo(ES) št. 470/2009.
Very common adverse reactions: - Mild to moderate inflammation at the injection site that typically resolves within four days but in some cases may persist for up to 12 days post-vaccination was observed in safety studies.
- v varnostnih študijah je bilo opaženo blago do zmerno vnetje na mestu injiciranja, ki ponavadi izzveni v roku štirih dni, v nekaterih primerih pa lahko vztraja do 12 dni po cepljenju.
Name and address of the manufacturers of the biological active substances:
Ime in naslov izdelovalca(izdelovalcev) biološke zdravilne učinkovine (zdravilnih učinkovin).
The following instructions should be used: the contents of a single vial of UNISTRAIN PRRS should be reconstituted with the contents of a single vial of ERYSENG PARVO.
Upoštevajte naslednje navodilo: vsebino ene viale UNISTRAIN PRRS zmešajte z vsebino ene viale ERYSENG PARVO.
Common adverse reactions: - A transient increase in body temperature within the first 6 hours after vaccination, which spontaneously resolves within 24 hours was observed in safety studies.
- v varnostnih študijah je bilo opaženo prehodno povišanje telesne temperature v prvih 6 urah po cepljenju, ki spontano izzveni v 24 urah.
E. rhusiopathiae: vaccination protects against swine erysipelas until the time of the recommended revaccination (approximately six months after the basic vaccination scheme), refer to section “Dosage for each species, route(s) and method of administration”.
E. rhusiopathiae: cepljenje varuje pred rdečico do takrat, ko je priporočena revakcinacija (približno šest mesecev po osnovni shemi cepljenja), glejte poglavje »Odmerki za posamezne živalske vrste ter pot(i) in način uporabe zdravila«.
However, the duration of immunity of the Erysipelas component following mixed use has not been investigated.
Trajanje imunosti komponente rdečice pri uporabi mešanega cepiva ni raziskana.
EXP {month/year} Once broached use immediately.
EXP {mesec/leto} Po odprtju uporabite takoj.
A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE
A. PROIZVAJALEC (PROIZVAJALCI) BIOLOŠKE (BIOLOŠKIH) UČINKOVINE (UČINKOVIN) IN PROIZVAJALEC (PROIZVAJALCI) ZDRAVILA, ODGOVOREN (ODGOVORNI) ZA SPROŠČANJE SERIJ
To stimulate active immunisation against porcine parvovirus and swine erysipelas.
Za stimulacijo aktivne imunizacije proti prašičjemu parvovirusu in rdečici.
Polyethylene (PET) bottles of 20, 50, 100 and 250 ml.
Polietilenske (PET) plastenke z vsebino 20, 50, 100 in 250 ml.
Aluminium hydroxide .............................................................................. 5.29 mg (aluminium) DEAE-Dextran
aluminijev hidroksid ............................................................................................. 5,29 mg (aluminij) DEAE-dekstran korenina pravega ženšena (ginsenga)
For simultaneous use with UNISTRAIN PRRS in sows for reproduction from 6 months of age, the mixed administration of ERYSENG PARVO and UNISTRAIN PRRS should only be used when vaccinating animals prior to mating.
Pri hkratni uporabi UNISTRAIN PRRS pri šest mesecev starih svinjah, namenjenih za razplod, mešanico cepiva ERYSENG PARVO in UNISTRAIN PRRS uporabite samo, če živali cepite pred paritvijo.
Potassium chloride Potassium dihydrogen phosphate Simethicone
Seznam pomožnih snovi aluminijev hidroksid DEAE-dekstran dinatrijev fosfat dodekahidrat korenina pravega ženšena (ginsenga) kalijev klorid kalijev dihidrogenfosfat simetikon natrijev klorid natrijev hidroksid voda za injekcije
Special precautions for use in animals
Posebni previdnostni ukrepi za uporabo pri živalih Jih ni.
10 doses (20 ml) 25 doses (50 ml) 50 doses (100 ml) 125 doses (250 ml)
10 odmerkov (20 ml) 25 odmerkov (50 ml) 50 odmerkov (100 ml) 125 odmerkov (250 ml)
For mixed use, the onset and duration of immunity of the parvovirus component and the onset of immunity of the Erysipelas component have been demonstrated to be equivalent to those determined for ERYSENG PARVO when used alone.
Dokazali so, da so pri uporabi mešanice cepiv nastop in trajanje imunosti pri komponenti rdečice in nastop imunosti pri parvovirusni komponenti enaki, kot če uporabimo samo cepivo ERYSENG PARVO.
Interaction with other medicinal products and other forms of interaction: Safety and efficacy data are available which demonstrate that this vaccine can be mixed with UNISTRAIN PRRS (where this vaccine is authorised) and administered at one injection site.
Na voljo so podatki o varnosti in učinkovitosti, ki dokazujejo, da to cepivo lahko mešamo s cepivom
No adverse reactions other than those mentioned in section 4.6 were observed after the administration of a 2-fold vaccine dose.
Po dajanju dvojnega odmerka cepiva niso opazili neželenih učinkov razen tistih, ki so navedeni v poglavju 4.6.
10 doses (20 ml) 25 doses (50 ml)
10 odmerkov (20 ml) 25 odmerkov (50 ml)
The mixed administration of UNISTRAIN PRRS and ERYSENG PARVO should only be used when vaccinating animals prior to mating.
Mešanico UNISTRAIN PRRS in ERYSENG PARVO injiciramo samo, ko cepimo živali pred paritvijo.
Safety and efficacy data are available which demonstrate that this vaccine can be mixed with UNISTRAIN PRRS (where this vaccine is authorised) and administered at one injection site.
UNISTRAIN PRRS (kjer je to cepivo registrirano) in ga lahko damo na enem mestu injiciranja.
Suspension for injection Whitish suspension
Suspenzija za injiciranje Suspenzija belkaste barve
Aluminium hydroxide ..................................................................................... 5.29 mg (aluminium) DEAE-Dextran
................................................... 5,29 mg (aluminij) DEAE-dekstran korenina pravega ženšena (ginsenga)
Cardboard box, (20 ml, 50 ml, 100ml, and 250ml) Bottles (100 ml, 250 ml) and vials (100 ml)
PODATKI NA ZUNANJI OVOJNINI IN STIČNI OZ. PRIMARNI OVOJNINI KARTONSKA ŠKATLA, (20 ml, 50 ml, 100ml in 250ml) plastenke (100 ml, 250 ml) in viale (100 ml)
No adverse reactions other than already mentioned under section “Adverse reactions” can be expected after the administration of a 2-fold vaccine dose.
Po dajanju dvojnega odmerka cepiva neželeni učinki razen tistih, ki so navedeni v poglavju »Neželeni učinki«, ni pričakovati.
Cardboard box with 1 PET bottle of 125 doses (250 ml).
Kartonska škatla z 1 PET-plastenko s 125 odmerki (250 ml).
Inactivated porcine parvovirus, strain NADL-2, ..................................................... RP > 1.15 * Inactivated Erysipelothrix rhusiopathiae, strain R32E11, .............. ELISA > 3.34 log2 IE50%** * RP - relative potency (ELISA).
inaktiviran prašičji parvovirus, sev NADL-2 .......................................................... RP > 1,15* inaktivirana bakterija Erysipelothrix rhusiopathiae, sev R32E11,…ELISA > 3,34 log2 IE50 %** *RP - relativna potenca (ELISA) ** IE50 % - inhibicija ELISA 50%
Cardboard box with 1 glass vial of 10 doses (20 ml).
Kartonska škatla z 1 stekleno vialo z 10 odmerki (20 ml).
Very rare adverse reactions: - Anaphylactic-type reactions have been reported in spontaneous reports and appropriate symptomatic treatment is recommended.
- Spontano so poročali o primerih reakcij anafilaktičnega tipa.
Inactivated porcine parvovirus, strain NADL-2, ....................................................... RP > 1.15, inactivated Erysipelothrix rhusiopathiae, strain R32E11, ................. ELISA > 3.34 log2 IE50%.
Inaktiviran prašičji parvovirus, sev NADL-2 ............................................................ RP > 1,15 inaktivirana bakterija Erysipelothrix rhusiopathiae, sev R32E11,…ELISA > 3,34 log2 IE50 % * * IE50 % - inhibicija ELISA 50%
Ask your veterinary surgeon or pharmacist how to dispose of medicines no longer required.
Glede odstranjevanja zdravil, ki jih ne uporabljate več, se posvetujte z veterinarjem Zdravilo odstranite na okolju prijazen način.
Cardboard box with 1 glass vial of 25 doses (50 ml).
Kartonska škatla z 1 stekleno vialo s 25 odmerki (50 ml).
Type I colourless glass vials of 20, 50 and 100 ml.
Brezbarvne viale iz stekla tipa I z vsebino 20, 50 in 100 ml. Viale so zaprte z gumijastim zamaškom in aluminijasto zaporko.
Cardboard box with 1 PET bottle of 10 doses (20 ml).
Kartonska škatla z 1 PET-plastenko z 10 odmerki (20 ml).
Cardboard box with 1 glass vial of 50 doses (100 ml).
Kartonska škatla z 1 stekleno vialo s 50 odmerki (100 ml).